英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

regulus    
n. 狮子座的一等星,熔渣

狮子座的一等星,熔渣

Regulus
n 1: the brightest star in Leo
2: a genus of birds of the family Sylviidae including kinglets
[synonym: {Regulus}, {genus Regulus}]

Regulus \Reg"u*lus\ (-l?s), n.; pl. E. {Reguluses} (-?z), L.
{Reguli} (-l?). [L., a petty king, prince, dim. of rex,
regis, a king: cf. F. r['e]gule. See {Regal}.]
1. A petty king; a ruler of little power or consequence.
[1913 Webster]

2. (Chem. & Metal.) The button, globule, or mass of metal, in
a more or less impure state, which forms in the bottom of
the crucible in smelting and reduction of ores.
[1913 Webster]

Note: The name was introduced by the alchemists, and applied
by them in the first instance to antimony. It signifies
little king; and from the facility with which antimony
alloyed with gold, these empirical philosophers had
great hopes that this metal, antimony, would lead them
to the discovery of the philosopher's stone. --Ure.
[1913 Webster]

3. (Astron.) A star of the first magnitude in the
constellation Leo; -- called also the {Lion's Heart}.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
regulus查看 regulus 在百度字典中的解释百度英翻中〔查看〕
regulus查看 regulus 在Google字典中的解释Google英翻中〔查看〕
regulus查看 regulus 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Regulus - Wikipedia
    Regulus is the brightest object in the constellation Leo and one of the brightest stars in the night sky It has the Bayer designation designated α Leonis, which is Latinized to Alpha Leonis, and abbreviated Alpha Leo or α Leo
  • Regulus Therapeutics Enters into Agreement to be Acquired by Novartis . . .
    SAN DIEGO, April 30, 2025 PRNewswire -- Regulus Therapeutics Inc (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into an agreement and plan of merger with Novartis AG ("Novartis") and an indirect
  • Regulus Therapeutics
    Our pipeline programs target kidney diseases of high unmet need, including ADPKD We are targeting the underlying biology of these diseases with a novel and potentially powerful approach: MicroRNA-based therapeutics News
  • Novartis announces commencement of tender offer to acquire Regulus . . .
    Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc , a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0 001 per share (the “Shares”), of Regulus Therapeutics Inc , a Delaware corporation (“Regulus”), in exchange for (i
  • Novartis grabs kidney drug developer Regulus in $1. 7bn deal
    Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could
  • Regulus Therapeutics Inc. (RGLS) - Yahoo Finance
    Regulus Therapeutics Inc , a clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States
  • Regulus Therapeutics (NASDAQ:RGLS) Sees Large Volume Increase - MarketBeat
    According to data from MarketBeat com, Regulus Therapeutics presently has a consensus rating of "Hold" and an average target price of $8 50 View Our Latest Report on Regulus Therapeutics Regulus Therapeutics Trading Down 3 8% The firm's fifty day moving average is $6 53 and its 200 day moving average is $3 18
  • Novartis to acquire Regulus Therapeutics and farabursen, an . . .
    Basel, April 30, 2025 – Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage biopharmaceutical company focused on developing microRNA therapeutics
  • Regulus Therapeutics Announces Positive Clinical and Regulatory Updates . . .
    Topline data from an interim analysis of the fourth cohort of its Phase 1b Multiple-Ascending Dose (MAD) clinical trial showed continued mechanistic dose response Exploratory results of imaging-based biomarkers continued to show reduction in height-adjusted total kidney volume (htTKV) growth rate
  • Technology - Regulus Therapeutics
    We believe that targeting pathways of human disease with antisense oligonucleotides targeting RNA biology represents a novel and potentially powerful therapeutic approach for multiple diseases We are beginning this work with therapies designed to target microRNA regulation of protein expression





中文字典-英文字典  2005-2009